These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5351928)

  • 1. Attempts to reverse the sickling process by therapy.
    Raper AB
    Ann Soc Belges Med Trop Parasitol Mycol; 1969; 49(2):205-10. PubMed ID: 5351928
    [No Abstract]   [Full Text] [Related]  

  • 2. Sickle cell disease: loss of the blood's WD40?
    Lancaster JR
    Trends Pharmacol Sci; 2003 Aug; 24(8):389-91. PubMed ID: 12915046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural features of erythrocyte and hemoglobin sickling.
    White JG
    Arch Intern Med; 1974 Apr; 133(4):545-62. PubMed ID: 4594393
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sickle cell anemia and the affinity of the blood for oxygen].
    Pocidalo JJ; Sinet M
    C R Seances Soc Biol Fil; 1979; 173(2):303-13. PubMed ID: 159755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickling as a function of oxygen delivery: effect of simulated transfusions of stored, fresh and inositol-hexaphosphate-loaded (low affinity) red cells.
    Kumpati J; Franco RS; Weiner M; Martelo OJ
    Blood Cells; 1982; 8(2):263-72. PubMed ID: 7159750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial blood pressure and hyperviscosity in sickle cell disease.
    Johnson CS
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):827-37, vi. PubMed ID: 16214646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell membrane abnormalities in sickle cell anemia.
    Bookchin RM; Lew VL
    Prog Hematol; 1983; 13():1-23. PubMed ID: 6322226
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology and treatment of sickle cell disease.
    Raphael RI
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):492-505. PubMed ID: 16167028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sickling process in relation to clinical manifestations.
    Bellingham AJ
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():23-5. PubMed ID: 4536364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (second of three parts).
    Dean J; Schechter AN
    N Engl J Med; 1978 Oct; 299(15):804-11. PubMed ID: 692564
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute splenic sequestration crisis in adults with sickle cell anemia.
    Koduri PR
    Am J Hematol; 2007 Feb; 82(2):174-5. PubMed ID: 16924644
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discocytes and echinocytes in sickle cell anemia. Investigation by scanning electron microscope].
    Bessis M; Döbler J; Mandon P
    Nouv Rev Fr Hematol; 1970; 10(1):63-74. PubMed ID: 4246338
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions between human hemoglobins: sickling and related phenomena.
    Bookchin RM; Nagel RL
    Semin Hematol; 1974 Oct; 11(4):577-95. PubMed ID: 4608956
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 19. Sickle cell anemia: closing the gap between theory and therapy.
    Foster S
    Am J Nurs; 1971 Oct; 71(10):1952-6. PubMed ID: 5209246
    [No Abstract]   [Full Text] [Related]  

  • 20. Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?
    Segel GB; Simon W; Lichtman MA
    Pediatr Blood Cancer; 2011 Jul; 57(1):8-9. PubMed ID: 21480473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.